Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
85.00
-2.00 (-2.30%)
Jan 26, 2026, 1:26 PM EST - Market open
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $851.32 million as of January 26, 2026. Its market cap has increased by 16,042.32% in one year.
Market Cap
851.32M
Enterprise Value
791.04M
1-Year Change
16,042.32%
Ranking
Category
Stock Price
$85.00
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $851.32M, an increase of 1,937.47%. That is a compound annual growth rate of 83.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 851.32M | 35.74% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | 41.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 917.05M |
| Xencor | 912.63M |
| Janux Therapeutics | 890.79M |
| Geron | 880.93M |
| YD Bio | 869.15M |
| Omeros | 845.84M |
| Valneva SE | 837.21M |
| Arvinas | 827.85M |